市场有望延续上行态势；看好管线即将兑现和前瞻布局的龙头药企

Group 1 - The market is expected to continue its upward trend, supported by strong resilience and a rebound after a brief adjustment [1] - The AI computing sector remains a focal point for investment, particularly following Nvidia's earnings report [1] - Current market stability is underpinned by supportive policies, technological advancements, and ongoing narratives against internal competition [2] Group 2 - The pharmaceutical industry is witnessing significant changes due to AI applications, with a notable increase in efficiency and innovation [3] - Major pharmaceutical companies are actively engaging in AI strategies, indicating a robust pipeline and forward-looking investments [3] - The return on investment in innovative research and development is accelerating, driven by advancements in technology [3]